After $105M funding round, ALX Oncology nabs FDA fast-track tag for cancer hopeful

cafead

Administrator
Staff member
  • cafead   Feb 18, 2020 at 11:22: AM
via It’s been a good month for ALX Oncology: After getting off a meaty $105 million series C last week, it’s started this week with two fast-track labels for its experimental drug.

article source